VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
INNV
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
INNVInnovAge Holding Corp.
$9.00$1.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksINNVBalance Sheet

InnovAge Holding Corp. (INNV) Balance Sheet

7Y historyFree accessUpdated daily

The company maintains a conservative capital structure with a debt-to-equity ratio of 0.32 and has bolstered liquidity, as cash and equivalents have surged to $97.9 million, providing a stable foundation for its turnaround efforts.

Income StatementBalance SheetCash FlowRatios

INNV Balance Sheet

Annual statement

INNV Balance Sheet

InnovAge Holding Corp. (INNV) balance sheet — 7-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMJun'25Jun'24Jun'23Jun'22Jun'21Jun'20Jun'19
Total Current Assets214.31M176.11M173.14M173.14M240.96M250.93M166.93M119.45M
Cash & Short-Term Investments141.33M105.92M102.79M102.78M184.45M203.7M114.56M61.2M
Cash Only97.89M64.14M56.96M56.95M184.45M203.7M114.56M61.2M
Short-Term Investments43.44M41.77M45.83M45.83M0000
Accounts Receivable45.67M39.68M51.43M51.43M42.67M37.98M48.05M55.01M
Days Sales Outstanding11.5616.9724.5827.2822.2921.7430.9243.12
Inventory00000000
Days Inventory Outstanding--------
Other Current Assets10K6.04M014K004.31M3.25M
Total Non-Current Assets343.08M381.12M406.69M374.52M321.92M287.68M242.7M243.78M
Property, Plant & Equipment187.5M194.94M221.44M221.44M176.26M142.72M102.49M101.19M
Fixed Asset Turnover5.22x4.38x3.45x3.11x3.96x4.47x5.53x4.60x
Goodwill142.05M0139.95M139.95M124.22M124.22M116.14M117.27M
Intangible Assets3.22M145.92M4.54M4.54M5.86M6.52M5.18M5.84M
Long-Term Investments02.2M5.45M2.65M5.49M3.49M15.89M15.43M
Other Non-Current Assets10.32M7.67M1.71M5.95M3.47M4.54M3M4.07M
Total Assets557.39M557.23M579.84M547.66M562.87M538.61M409.63M363.23M
Asset Turnover1.85x1.53x1.32x1.26x1.24x1.18x1.38x1.28x
Asset Growth %-0.77%-3.9%5.87%-2.7%4.5%31.49%12.77%-
Total Current Liabilities203.89M164.81M138.6M138.6M105.31M78.56M76.63M83.46M
Accounts Payable115.36M76.75M55.46M55.46M50.56M32.36M28.88M30.35M
Days Payables Outstanding34.8104.1832.0434.532.7624.8124.7531.21
Short-Term Debt13.4M12.17M12.54M3.79M7.16M5.87M3.43M3.63M
Deferred Revenue (Current)275K0000000
Other Current Liabilities75.13M75.89M70.6M55.4M47.58M40.34M44.32M49.48M
Current Ratio1.05x1.07x1.25x1.25x2.29x3.19x2.18x1.43x
Quick Ratio1.05x1.07x1.25x1.25x2.29x3.19x2.18x1.43x
Cash Conversion Cycle-23.24-------
Total Non-Current Liabilities84.73M129.51M141.43M109.25M103.82M102.08M225.25M198.33M
Long-Term Debt45.52M57.46M61.48M61.48M68.21M71.57M210.43M186.82M
Capital Lease Obligations84.2M31.45M39.02M39.02M9.44M5.19M4.09M4.33M
Deferred Tax Liabilities36.61M39.14M39.63M7.46M25.04M22.56M9.28M6.11M
Other Non-Current Liabilities2.13M1.46M1.3M1.3M1.13M2.76M1.45M1.08M
Total Liabilities288.62M294.32M280.03M247.85M209.13M180.65M301.88M281.79M
Total Debt86.95M101.08M113.03M113.03M84.81M82.63M217.96M194.78M
Net Debt-10.94M36.94M56.08M56.09M-99.64M-121.07M103.39M133.58M
Debt / Equity0.32x0.38x0.38x0.38x0.24x0.23x2.02x2.39x
Debt / EBITDA2.78x---8.91x0.95x3.50x4.00x
Net Debt / EBITDA-0.35x----10.47x-1.39x1.66x2.74x
Interest Coverage18.10x-3.50x-4.42x-32.37x-1.87x-1.08x3.44x3.85x
Total Equity268.78M262.91M299.81M299.81M353.74M357.96M107.75M81.44M
Equity Growth %-2.31%-12.31%0%-15.25%-1.18%232.22%32.3%-
Book Value per Share1.961.942.212.212.612.640.810.61
Total Shareholders' Equity235.6M234.97M269.26M269.26M332.36M334.56M101.02M74.19M
Common Stock137K137K137K136K136K136K133K133K
Retained Earnings-105.76M-101.05M-68.31M-68.31M4.73M10.66M64.74M38.46M
Treasury Stock-7.5M-7.5M-179K-179K00-193K-193K
Accumulated OCI00000000
Minority Interest33.17M27.94M30.55M30.55M21.38M23.41M6.74M7.25M

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrained
Balance SheetAdequate
Cash FlowImproving
Top Statement Risk

Goodwill impairment risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q4)

Asset Base Contractions Mask Operational Shift

InnovAge's total assets have declined from $579.8M in 2024Q4 to $557.4M in 2026Q4, a 3.9% reduction, despite revenue acceleration, suggesting a strategic simplification of the balance sheet away from expansionary capital.

The asset contraction appears driven by a net reduction in total liabilities and a decline in property, plant, and equipment, which fell from $221.4M to $187.5M over the period. This trend may indicate a pause in new center construction or a shift toward optimizing existing sites rather than pursuing asset-heavy geographic expansion, consistent with a post-sanction recovery phase focused on stabilization.

Low Leverage Provides Strategic Flexibility

As of 2026Q4, InnovAge's debt-to-equity ratio stands at a conservative 0.32, based on $87.0M in total debt against $235.6M in equity, providing ample capacity for strategic investments or to absorb potential operational setbacks.

The debt load has fluctuated but remains modest relative to equity, suggesting the company is not reliant on leverage for growth. The recent increase from $38.4M in 2026Q3 to $87.0M may indicate a deliberate draw on credit facilities to bolster cash reserves ahead of anticipated operational needs, a prudent move given the business's regulatory sensitivity.

PPE Decline Signals Capacity Utilization Phase

Net property, plant, and equipment has decreased by $33.9M, or 15.3%, since 2024Q4, while goodwill has remained stable at around $142M, suggesting the company's primary capital allocation is currently focused on service delivery within existing infrastructure.

The decline in PPE net value, likely due to depreciation outpacing new capital expenditures, aligns with a strategy of maximizing participant density in existing PACE centers to drive operating leverage. The static goodwill balance indicates no recent acquisition activity, focusing the balance sheet risk profile entirely on operational execution rather than integration or impairment of past deals.

Cash Surge Bolsters Operational Runway

Cash and cash equivalents have more than doubled since 2025Q1, reaching $97.9M in 2026Q4, and the current ratio has stabilized above 1.0, providing a significant liquidity buffer against the volatility inherent in medical cost reporting.

This cash accumulation, occurring alongside debt increases, appears to be a deliberate treasury strategy to ensure ample liquidity. The improved cash position significantly reduces near-term financial risk and provides the operational flexibility needed to manage potential IBNR reserve adjustments or temporary reimbursement delays common in capitated government contracts.

Persistent Deficits Reflect Turnaround Costs

Cumulative retained earnings remain deeply negative at -$105.8M as of 2026Q4, though the deficit has widened modestly over the last two quarters, indicating that recent operational improvements have not yet fully offset historical losses.

The negative retained earnings are a direct result of past losses incurred during the regulatory sanctions and operational scaling phases. The recent sequential deepening of this deficit, even as the company posts quarterly profits, suggests that one-time or non-cash charges may still be weighing on the equity base, warranting a closer look at the components of net income.

Static Goodwill Amid Operational Recovery

Goodwill has remained unchanged at approximately $142M for eight consecutive quarters, a significant figure representing over 25% of total assets, which poses a potential impairment risk if the turnaround in participant economics stalls.

In a business where value is heavily tied to the regulatory approval and local market dominance of each PACE center, a static goodwill balance implies that past acquisition premiums have not been reassessed. If the company fails to achieve sustained profitability and participant growth at existing centers, this intangible asset could come under scrutiny, potentially leading to a material non-cash charge that would further erode the already negative equity base.

INNV — Frequently Asked Questions

Quick answers to the most common questions about buying INNV stock.

What are the total assets of InnovAge Holding Corp. (INNV)?

As of 2025, InnovAge Holding Corp. (INNV) had total assets of $557.2M including $176.1M in current assets.

How much debt does InnovAge Holding Corp. (INNV) have?

InnovAge Holding Corp. (INNV) carries total debt of $101.1M, offset by $105.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of InnovAge Holding Corp.?

InnovAge Holding Corp. (INNV) has total shareholders' equity (book value) of $235.0M ($1.94 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is InnovAge Holding Corp.'s current ratio and liquidity?

InnovAge Holding Corp. (INNV) reported a current ratio of 1.07x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.